Trial Profile
Impact of Two Prednisone-free Maintenance Immunosuppressive Regimens With Reduced Dose FK506+Everolimus vs. Standard Dose Tacrolimus (FK506)+ Mycophenolate Mofetil (MMF) on Subpopulation of T and B Cells, Renal Allograft Function and Gene Expression Profiles in Renal Allograft Biopsies at 12 Months Post-transplant. Prospective Single Center Study in Recipients of Renal Transplant Allograft
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Transplant rejection
- Focus Pharmacodynamics; Therapeutic Use
- 10 Feb 2021 Status changed from active, no longer recruiting to completed.
- 12 Sep 2017 Planned End Date changed from 1 May 2018 to 1 Jun 2020.
- 12 Sep 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2020.